These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 21968742)

  • 1. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
    Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis.
    Yeremenko N; Noordenbos T; Cantaert T; van Tok M; van de Sande M; Cañete JD; Tak PP; Baeten D
    Arthritis Rheum; 2013 Jan; 65(1):174-85. PubMed ID: 22972410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
    Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
    Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
    van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis.
    Rihl M; Kellner H; Kellner W; Barthel C; Yu DT; Tak PP; Zeidler H; Baeten D
    Arthritis Rheum; 2008 Nov; 58(11):3430-5. PubMed ID: 18975340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
    Chabaud M; Durand JM; Buchs N; Fossiez F; Page G; Frappart L; Miossec P
    Arthritis Rheum; 1999 May; 42(5):963-70. PubMed ID: 10323452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
    Chabaud M; Miossec P
    Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
    van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
    Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
    Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
    Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis.
    Kruithof E; Baeten D; De Rycke L; Vandooren B; Foell D; Roth J; Cañete JD; Boots AM; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(3):R569-80. PubMed ID: 15899044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
    Ju JH; Heo YJ; Cho ML; Jhun JY; Park JS; Lee SY; Oh HJ; Moon SJ; Kwok SK; Park KS; Park SH; Kim HY
    Arthritis Rheum; 2012 Nov; 64(11):3543-52. PubMed ID: 22736176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.